Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Apr 24 04:00PM ET
30.26
Dollar change
+0.31
Percentage change
1.04
%
IndexRUT P/E- EPS (ttm)-0.00 Insider Own4.28% Shs Outstand54.72M Perf Week4.34%
Market Cap1.66B Forward P/E15.54 EPS next Y1.95 Insider Trans-4.84% Shs Float52.39M Perf Month-7.60%
Income1.32M PEG- EPS next Q0.26 Inst Own106.72% Short Float9.21% Perf Quarter7.80%
Sales607.52M P/S2.73 EPS this Y-30.39% Inst Trans1.11% Short Ratio12.36 Perf Half Y27.36%
Book/sh16.84 P/B1.80 EPS next Y18.94% ROA0.08% Short Interest4.82M Perf Year-19.76%
Cash/sh4.66 P/C6.50 EPS next 5Y1.69% ROE0.15% 52W Range21.99 - 38.61 Perf YTD4.56%
Dividend Est.- P/FCF14.98 EPS past 5Y-59.02% ROI0.14% 52W High-21.63% Beta1.01
Dividend TTM- Quick Ratio1.43 Sales past 5Y9.22% Gross Margin72.24% 52W Low37.61% ATR (14)1.24
Dividend Ex-Date- Current Ratio1.70 EPS Y/Y TTM-97.75% Oper. Margin2.21% RSI (14)44.37 Volatility3.80% 3.81%
Employees652 Debt/Eq0.05 Sales Y/Y TTM-8.95% Profit Margin0.22% Recom1.50 Target Price40.50
Option/ShortYes / Yes LT Debt/Eq0.04 EPS Q/Q-94.81% Payout0.00% Rel Volume0.52 Prev Close29.95
Sales Surprise5.99% EPS Surprise59.50% Sales Q/Q-1.80% EarningsFeb 27 AMC Avg Volume390.05K Price30.26
SMA20-4.13% SMA50-3.23% SMA2004.05% Trades Volume201,715 Change1.04%
Date Action Analyst Rating Change Price Target Change
Jan-03-23Resumed Jefferies Buy $44 → $45
Dec-01-21Resumed Jefferies Buy $40 → $44
Apr-13-21Upgrade Jefferies Hold → Buy $25 → $40
Jun-16-20Upgrade Piper Sandler Neutral → Overweight $25 → $31
Jun-15-20Resumed Jefferies Hold $24
Nov-08-19Downgrade Berenberg Buy → Hold
Nov-07-19Downgrade Stifel Buy → Hold $55 → $23
Nov-06-19Downgrade Jefferies Buy → Hold $46 → $23
Nov-12-18Reiterated B. Riley FBR Buy $68 → $65
Jan-18-18Reiterated B. Riley FBR, Inc. Buy $54
Apr-24-24 04:05PM
Apr-08-24 12:11PM
08:00AM
Mar-27-24 04:37PM
Mar-06-24 04:30PM
08:28PM Loading…
Mar-04-24 08:28PM
Feb-28-24 04:30PM
09:19AM
07:17AM
Feb-27-24 07:30PM
06:50PM
06:02PM
05:00PM
04:05PM
Feb-26-24 09:15AM
10:00AM Loading…
Feb-20-24 10:00AM
Feb-13-24 04:05PM
Feb-05-24 08:30AM
Dec-19-23 07:30AM
Dec-14-23 07:43PM
Nov-18-23 05:03AM
Nov-10-23 12:10PM
Nov-09-23 09:54AM
Nov-08-23 07:30PM
07:15PM
06:08PM
04:05PM
Nov-07-23 04:30PM
Nov-02-23 07:00AM
Nov-01-23 10:01AM
04:15PM Loading…
Oct-25-23 04:15PM
Oct-16-23 05:34PM
Oct-09-23 04:45PM
Sep-27-23 04:15PM
Sep-26-23 07:37PM
Sep-09-23 08:00PM
Aug-31-23 05:30PM
Aug-21-23 09:00AM
Aug-08-23 08:30PM
07:55PM
06:40PM
04:17PM
Jul-28-23 02:56PM
Jul-25-23 06:36AM
Jul-24-23 04:05PM
Jun-27-23 11:50AM
Jun-21-23 08:00PM
Jun-10-23 07:40AM
May-31-23 04:15PM
May-11-23 08:39AM
May-10-23 11:23AM
May-09-23 08:30PM
07:05PM
06:09PM
04:05PM
May-02-23 04:05PM
Apr-26-23 08:00PM
Apr-25-23 04:15PM
Apr-03-23 04:05PM
Mar-31-23 12:41PM
Mar-30-23 05:22PM
Mar-08-23 04:05PM
Mar-02-23 08:29PM
Mar-01-23 04:55PM
05:50AM
Feb-28-23 05:25PM
04:05PM
Feb-21-23 10:00AM
Feb-14-23 04:30PM
09:27AM
Feb-09-23 06:15PM
Jan-18-23 08:11AM
Jan-03-23 07:11AM
Dec-30-22 12:46AM
Dec-01-22 02:37PM
Nov-22-22 05:00PM
Nov-11-22 05:52AM
Nov-08-22 07:25PM
05:30PM
04:05PM
Oct-25-22 04:30PM
Oct-10-22 08:30AM
Sep-07-22 09:03AM
Aug-31-22 04:00PM
08:55AM
Aug-11-22 08:59AM
Aug-08-22 10:00AM
Aug-04-22 05:25PM
04:01PM
Jul-25-22 05:00PM
Jul-11-22 11:45AM
Jun-02-22 04:05PM
May-09-22 04:05PM
May-02-22 04:55PM
03:08PM
08:30AM
Apr-29-22 08:00PM
Apr-13-22 04:11PM
Apr-07-22 03:18PM
Apr-04-22 05:00PM
Supernus Pharmaceuticals, Inc. engages in the development and commercialization of products for the treatment of central nervous system diseases. It offers Trokendi XR, Oxtellar XR, APOKYN, XADAGO, and MYOBLOC products. The company was founded by Jack A. Khattar on March 30, 2005, and is headquartered in Rockville, MD.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Bhatt Padmanabh P.Sr. VP of IP, CSOMar 21 '24Option Exercise25.3014,491366,62223,061Mar 25 05:00 PM
Bhatt Padmanabh P.Sr. VP of IP, CSOMar 21 '24Sale35.3114,491511,6778,570Mar 25 05:00 PM
Bhatt Padmanabh P.Sr. VP of IP, CSOMar 20 '24Option Exercise25.3040010,1208,970Mar 22 05:00 PM
Bhatt Padmanabh P.Sr. VP of IP, CSOMar 20 '24Sale35.3140014,1248,570Mar 22 05:00 PM
Bhatt Padmanabh P.Sr. VP of IP, CSOMar 19 '24Option Exercise25.3012,364312,80920,934Mar 21 05:01 PM
Bhatt Padmanabh P.Sr. VP of IP, CSOMar 19 '24Sale35.3112,364436,5738,570Mar 21 05:01 PM
Bhatt Padmanabh P.Sr. VP of IP, CSOMar 13 '24Option Exercise17.6162,3661,098,52344,686Mar 15 06:39 PM
Bhatt Padmanabh P.Sr. VP of IP, CSOMar 13 '24Sale33.7462,3662,104,2898,570Mar 15 06:39 PM
Bhatt Padmanabh P.Sr. VP of IP, CSOMar 12 '24Option Exercise12.983,88450,41412,454Mar 14 05:00 PM
Bhatt Padmanabh P.Sr. VP of IP, CSOMar 12 '24Sale32.993,884128,1338,570Mar 14 05:00 PM
Khattar Jack A.President, CEOFeb 28 '24Option Exercise0.0035,0000932,005Feb 29 05:00 PM
Mottola FrankSVP, Quality, GMP, Ops, ITFeb 28 '24Option Exercise0.0099008,239Feb 29 05:01 PM
Bhatt Padmanabh P.Sr. VP of IP, CSOFeb 26 '24Option Exercise9.135,00045,65013,570Feb 28 05:01 PM
Bhatt Padmanabh P.Sr. VP of IP, CSOFeb 26 '24Sale30.215,000151,0508,570Feb 28 05:01 PM
Martin Tami TillotsonSr. V.P., Regulatory AffairsJan 10 '24Option Exercise9.248,00073,92093,664Jan 12 05:00 PM
Martin Tami TillotsonSr. V.P., Regulatory AffairsJan 10 '24Sale27.918,000223,28085,664Jan 12 05:00 PM
Rubin JonathanSr. VP, Chief Medical OfficerDec 22 '23Option Exercise0.0060003,447Dec 26 05:01 PM
Khattar Jack A.President, CEODec 22 '23Option Exercise0.0025,0000892,463Dec 26 05:00 PM
NEWHALL CHARLES W IIIDirectorNov 16 '23Option Exercise9.247,45768,903119,589Nov 20 05:00 PM
NEWHALL CHARLES W IIIDirectorNov 16 '23Sale28.012,50070,025117,089Nov 20 05:00 PM
Hudson Frederick M.DirectorNov 15 '23Option Exercise9.247,45768,90342,324Nov 17 05:00 PM
Hudson Frederick M.DirectorNov 15 '23Sale28.509,093259,15033,231Nov 17 05:00 PM
Mottola FrankSVP, Quality, GMP, Ops, ITNov 14 '23Option Exercise9.242,00018,4806,791Nov 16 05:00 PM
Mottola FrankSVP, Quality, GMP, Ops, ITNov 14 '23Sale28.131,11031,2245,681Nov 16 05:00 PM
DEC TIMOTHY CSenior Vice-President & CFOOct 13 '23Option Exercise0.004,00007,000Oct 13 05:00 PM
Khattar Jack A.President, CEOSep 07 '23Option Exercise0.0035,0000884,267Sep 07 05:00 PM
Bhatt Padmanabh P.Sr. VP of IP, CSOSep 07 '23Option Exercise0.002,50008,347Sep 07 05:00 PM
Martin Tami TillotsonSr. V.P., Regulatory AffairsAug 30 '23Option Exercise23.998,100194,31993,349Sep 01 05:00 PM
Martin Tami TillotsonSr. V.P., Regulatory AffairsAug 30 '23Sale32.008,100259,20085,249Sep 01 05:00 PM
Martin Tami TillotsonSr. V.P., Regulatory AffairsAug 25 '23Sale31.595,135162,21585,249Aug 29 05:00 PM
Khattar Jack A.President, CEOMay 11 '23Option Exercise0.0031,2500864,272May 12 05:00 PM
DEC TIMOTHY CSenior Vice-President & CFOMay 11 '23Option Exercise0.001,50003,359May 12 05:00 PM
Bhatt Padmanabh P.Sr. VP of IP, CSOMay 11 '23Option Exercise0.0075005,497May 12 05:00 PM